Nestle has a newly-acquired company, and it is the protein shake maker, Orgain. The latter produces plant-based bars, shakes, and protein powders, and the Swiss multinational food and drink processing company headquartered in Vevey, Vaud, Switzerland, bought a majority stake for an undisclosed amount.
Andrew Abraham, Orgain's founder, and Butterfly Equity will remain shareholders of the company once the deal is completed. According to Food Dive, the agreement between Nestle and Orgain includes the option for the former to buy the rest of the shares in the company in 2024. Abraham will also retain his position as the chief executive officer of Orgain.
It was said that the stake acquisition will push and step up Nestlé's efforts to grow its health and wellness business unit. To attain its goal, the company will also be removing some of its divisions that are growing slowly compared to the others.
In fact, Nestlé already offloaded its confections and ice cream businesses and last year, it has also disposed of the majority of its North American bottled waters business for $4.3 billion as it was already struggling to stay afloat.
With its new deal with Orgain, Nestle will also be able to focus more on its other international premium brands that have big potential to grow further such as Perrier. Orgain will also give the firm fresh products to offer especially with the growing demand for plant-based items around the world. Furthermore, Orgain will give Nestle a deeper presence in trendy categories that are becoming really popular with consumers.
"Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges," Nestlé Health Science chief executive officer, Greg Behar, said in a press release. "Orgain's emphasis on clean, all natural, plant-based, organic ingredients has made it a leader in the U.S., and we look forward to combining our companies' expertise to bring Orgain to more people around the world."
Dr. Abraham, CEO and Founder of Orgain, also said, "We've worked hard to develop innovative products that make a real difference in consumers' lives, and now through Nestlé Health Science's capabilities, resources and dedication to nutrition, we will be able to reach more people around the world."
Meanwhile, the acquisition deal is still subject to customary regulatory approvals.


China’s November Economic Data Signals Slowing Industrial Output and Weak Consumer Demand
Gold and Silver Prices Dip as Markets Await Key U.S. Economic Data
Australian Consumer Sentiment Slumps in Early December as Inflation Fears Resurface
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Asian Currencies Slip as Dollar Strengthens; Indian Rupee Rebounds on Intervention Hopes
Chinese Robotaxi Stocks Rally as Tesla Boosts Autonomous Driving Optimism
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
Dollar Struggles as Markets Eye Key Central Bank Decisions and Global Rate Outlooks
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Asian Fund Managers Turn More Optimistic on Growth but Curb Equity Return Expectations: BofA Survey
Bank of Japan Poised for Historic Rate Hike as Inflation Pressures Persist
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 



